アポトーシス市場：用途別、モダリティ別、エンドユーザー別、地域別

アポトーシスの世界市場は、2024年には38億1,000万米ドルと推定され、2031年には56億5,000万米ドルに達すると予測され、2024年から2031年までのCAGRは5.8%です。

図.アポトーシス市場シェア（%）、地域別、2024年

一般にプログラムされた細胞死として知られるアポトーシスは、不要な細胞や損傷を受けた細胞を制御された方法で除去する、生物における自然なプロセスです。アポトーシスの調節不全は、がん、自己免疫疾患、神経変性疾患のような病的状態につながる可能性があります。そのため、このような疾患の治療のためにアポトーシスを調節する新しい標的治療薬の研究開発がこの市場の成長に寄与しています。アポトーシスの分子メカニズムの解明と新規経路阻害剤の開発が進んだことで、用途が拡大し、アポトーシス調節薬の需要が世界的に高まっています。

市場力学：

がんやその他のアポトーシス関連疾患の有病率の上昇、製薬企業による研究開発投資の増加、新規の標的アポトーシス調節薬に対するUSFDA承認の増加は、予測期間中に世界のアポトーシス市場を推進すると予測される主要因の一部です。WHOによると、がんの負担は今後20年間で70％増加すると予想されています。しかし、薬剤開拓や臨床試験に伴う高コストが市場成長の妨げになる可能性があります。プラス面では、アジア太平洋やラテンアメリカなどの新興市場は、これらの地域における医療費の増加や質の高い医療への需要により、市場プレーヤーにとって有利な機会を提供しています。さらに、併用療法やパイプライン医薬品の継続的な調査により、今後数年にわたって新たな展望が生まれ続けると思われます。

本調査の主な特徴

本レポートは、世界のアポトーシス市場を詳細に分析し、2023年を基準年とした予測期間（2024-2031年）の市場規模および複合年間成長率（CAGR%）を提供しています。

また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリックスについて解説しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界のアポトーシス市場における主要企業プロファイルを掲載しています。

主要企業には、アボット、ロシュ、ノバルティス、ブリストル・マイヤーズスクイブ、メルク、ファイザーなどが含まれます。

本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

アポトーシスの世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。

利害関係者は、世界のアポトーシス市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 主な発展
• 規制シナリオ
• 買収と提携のシナリオ
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界のアポトーシス市場- コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界のアポトーシス市場、アプリケーション別、2019年-2031年

• 腫瘍学
• 神経変性疾患
• 自己免疫疾患
• 心血管疾患
• その他

第6章 世界のアポトーシス市場、モダリティ別、2019年-2031年

• アポトーシスアッセイ
• アポトーシス抗体
• アポトーシスの阻害剤と誘導剤

第7章 世界のアポトーシス市場、エンドユーザー別、2019年-2031年

• 製薬・バイオテクノロジー企業
• 学術研究機関
• 契約研究機関
• その他

第8章 世界のアポトーシス市場、地域別、2019年-2031年

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• 企業プロファイル
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories
  • GE Healthcare
  • Becton, Dickinson and Company（BD）
  • Promega Corporation
  • Sartorius AG
  • Abcam plc.
  • Biotium
  • Geno Technology
  • BioTek Instruments
  • Canvax
  • Abnova
  • Creative Bioarray
  • PerkinElmer
  • Danaher Corporation
  • Bio-Techne
  • GeneCopoeia, Inc.
  • Takara Bio Inc.
  • Bioss Antibodies

第10章 アナリストの推奨事項

第11章 調査手法

• 参考文献
• 調査手法

The Global Apoptosis Market is estimated to be valued at USD 3.81 Billion in 2024 and is expected to reach USD 5.65 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.

Figure. Apoptosis Market Share (%), By Region, 2024

Apoptosis, commonly known as programmed cell death, is a natural process in living organisms to remove unnecessary or damaged cells in a controlled manner. Dysregulation of apoptosis can lead to pathogenic conditions like cancer, autoimmune disorders, and neurodegenerative diseases. Therefore, research and development of new targeted therapeutics to modulate apoptosis for treatment of such diseases is contributing to the growth of this market. Advancements in understanding the molecular mechanisms of apoptosis and development of novel pathway inhibitors are expanding the applications and driving the demand for apoptosis modulating drugs globally.

Market Dynamics:

Rise in prevalence of cancer and other apoptosis related disorders, increasing R&D investments by pharmaceutical companies, and growing USFDA approvals for novel targeted apoptosis modulating drugs are some of the major factors projected to propel the global apoptosis market during the forecast period. According to WHO, cancer burden is expected to grow by 70% in the next two decades. However, high costs associated with drug development and clinical trials may hamper market growth. On the positive side, emerging markets such as Asia Pacific and Latin America offer lucrative opportunities for market players due to growing healthcare expenditure and demand for quality care in these regions. Furthermore, ongoing research on combination therapies and pipeline drugs will continue creating new prospects over the coming years.

Key features of the study:

This report provides in-depth analysis of the global apoptosis market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global apoptosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbot, Roche, Novartis, Bristol-Myers Squibb, Merck, and Pfizer

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global apoptosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global apoptosis market.

Detailed Segmentation-

• By Application Insights (Revenue, USD Bn, 2019 - 2031)
  • Oncology
  • Neurodegenerative Diseases
  • Autoimmune Disorders
  • Cardiovascular Diseases
  • Others
• By Modality Insights (Revenue, USD Bn, 2019 - 2031)
  • Apoptosis Assays
  • Apoptosis Antibodies
  • Apoptosis Inhibitors and Inducers
• By End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations
  • Ohers
• Regional Insights (Revenue, USD Bn 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories
  • GE Healthcare
  • Becton, Dickinson and Company (BD)
  • Promega Corporation
  • Sartorius AG
  • Abcam plc.
  • Biotium
  • Geno Technology
  • BioTek Instruments
  • Canvax
  • Abnova
  • Creative Bioarray
  • PerkinElmer
  • Danaher Corporation
  • Bio-Techne
  • GeneCopoeia, Inc.
  • Takara Bio Inc.
  • Bioss Antibodies

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Application
  • Market Snapshot, By Modality
  • Market Snapshot, By End User
  • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Apoptosis Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Apoptosis Market, By Application, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oncology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Neurodegenerative Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Autoimmune Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Cardiovascular Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Apoptosis Market, By Modality, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Apoptosis Assays
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Apoptosis Antibodies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Apoptosis Inhibitors and Inducers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Apoptosis Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Pharmaceutical and Biotechnology Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Academic and Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Contract Research Organizations
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Apoptosis Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Merck KGaA
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Thermo Fisher Scientific, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bio-Rad Laboratories
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GE Healthcare
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Becton, Dickinson and Company (BD)
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Promega Corporation
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sartorius AG
  • Abcam plc.
  • Biotium
  • Geno Technology
  • BioTek Instruments
  • Canvax
  • Abnova
  • Creative Bioarray
  • PerkinElmer
  • Danaher Corporation
  • Bio-Techne
  • GeneCopoeia, Inc.
  • Takara Bio Inc.
  • Bioss Antibodies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. Research Methodology

• References
• Research Methodology
• About us and Sales Contact